VistaGen Therapeutics Inc. (VTGN)
NASDAQ · Healthcare
VistaGen Therapeutics Inc. Net Income 2011–2025
VistaGen Therapeutics Inc. annual/quarterly net income history and growth rate from 2011 to 2025. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- VistaGen Therapeutics Inc. net income for the quarter ending December 31, 2025 was -18.9 M, a 34.14% increase year-over-year.
- VistaGen Therapeutics Inc. net income for the twelve months ending December 31, 2025 was -67.5 M, a 84.27% increase year-over-year.
- VistaGen Therapeutics Inc. annual net income for 2025 was -51.4 M, a 75.12% increase from 2024.
- VistaGen Therapeutics Inc. annual net income for 2024 was -29.4 M, a 50.44% decrease from 2023.
- VistaGen Therapeutics Inc. annual net income for 2023 was -59.2 M, a 24.05% increase from 2022.
- VistaGen Therapeutics Inc. annual net income for 2022 was -47.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
VistaGen Therapeutics Inc. Net Income — FAQ
VistaGen Therapeutics Inc. (VTGN) net income over the last 12 years — annual and quarterly figures with year-over-year growth and charts.
What is VistaGen Therapeutics Inc.'s net income?
VistaGen Therapeutics Inc. (VTGN) reported net income of -$51M for fiscal 2025.
Where can I see VTGN's net income history?
The chart and table above show VistaGen Therapeutics Inc.'s net income by year and by quarter, including the growth rate.